Sitokiren Malate
苹果酸司妥吉仑
Report date: 2026/01/07 16:47:53
NME
Base Information
Drug NameSitokiren Malate
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2025/12/03
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe PharmaShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesSph (Benxi) North Pharmaceutical Co LtdMitsubishi Tanabe Pharma CorpJanssen Research & Development Llc +[5]
Inactive CompaniesShanghai Pharma Biotherapeutics USA Inc
Active Indications +[6]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A